276 related articles for article (PubMed ID: 29108819)
1. Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease.
Nossent EJ; Antigny F; Montani D; Bogaard HJ; Ghigna MR; Lambert M; Thomas de Montpréville V; Girerd B; Jaïs X; Savale L; Mercier O; Fadel E; Soubrier F; Sitbon O; Simonneau G; Vonk Noordegraaf A; Humbert M; Perros F; Dorfmüller P
J Heart Lung Transplant; 2018 May; 37(5):647-655. PubMed ID: 29108819
[TBL] [Abstract][Full Text] [Related]
2. Unique wreath-like smooth muscle proliferation of the pulmonary vasculature in pulmonary veno-occlusive disease versus pulmonary arterial hypertension.
Lai YJ; Chen PR; Huang YL; Hsu HH
J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):300-309. PubMed ID: 31202500
[TBL] [Abstract][Full Text] [Related]
3. Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.
Montani D; Girerd B; Jaïs X; Levy M; Amar D; Savale L; Dorfmüller P; Seferian A; Lau EM; Eyries M; Le Pavec J; Parent F; Bonnet D; Soubrier F; Fadel E; Sitbon O; Simonneau G; Humbert M
Lancet Respir Med; 2017 Feb; 5(2):125-134. PubMed ID: 28087362
[TBL] [Abstract][Full Text] [Related]
4. Lipidomic Profile Analysis of Lung Tissues Revealed Lipointoxication in Pulmonary Veno-Occlusive Disease.
Khoury S; Beauvais A; Colas J; Saint-Martin Willer A; Perros F; Humbert M; Vandebrouck C; Montani D; Ferreira T; Antigny F
Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551306
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Human and Experimental Pulmonary Veno-Occlusive Disease.
Manaud G; Nossent EJ; Lambert M; Ghigna MR; Boët A; Vinhas MC; Ranchoux B; Dumas SJ; Courboulin A; Girerd B; Soubrier F; Bignard J; Claude O; Lecerf F; Hautefort A; Florio M; Sun B; Nadaud S; Verleden SE; Remy S; Anegon I; Bogaard HJ; Mercier O; Fadel E; Simonneau G; Vonk Noordegraaf A; Grünberg K; Humbert M; Montani D; Dorfmüller P; Antigny F; Perros F
Am J Respir Cell Mol Biol; 2020 Jul; 63(1):118-131. PubMed ID: 32209028
[TBL] [Abstract][Full Text] [Related]
6. GCN2 Regulates ATF3-p38 MAPK Signaling Transduction in Pulmonary Veno-Occlusive Disease.
Chen Z; Zhang J; Wei D; Chen J; Yang J
J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):677-689. PubMed ID: 33988041
[TBL] [Abstract][Full Text] [Related]
7. EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension.
Eyries M; Montani D; Girerd B; Perret C; Leroy A; Lonjou C; Chelghoum N; Coulet F; Bonnet D; Dorfmüller P; Fadel E; Sitbon O; Simonneau G; Tregouët DA; Humbert M; Soubrier F
Nat Genet; 2014 Jan; 46(1):65-9. PubMed ID: 24292273
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic Characterization of
Hadinnapola C; Bleda M; Haimel M; Screaton N; Swift A; Dorfmüller P; Preston SD; Southwood M; Hernandez-Sanchez J; Martin J; Treacy C; Yates K; Bogaard H; Church C; Coghlan G; Condliffe R; Corris PA; Gibbs S; Girerd B; Holden S; Humbert M; Kiely DG; Lawrie A; Machado R; MacKenzie Ross R; Moledina S; Montani D; Newnham M; Peacock A; Pepke-Zaba J; Rayner-Matthews P; Shamardina O; Soubrier F; Southgate L; Suntharalingam J; Toshner M; Trembath R; Vonk Noordegraaf A; Wilkins MR; Wort SJ; Wharton J; ; Gräf S; Morrell NW
Circulation; 2017 Nov; 136(21):2022-2033. PubMed ID: 28972005
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology.
Montani D; Achouh L; Dorfmüller P; Le Pavec J; Sztrymf B; Tchérakian C; Rabiller A; Haque R; Sitbon O; Jaïs X; Dartevelle P; Maître S; Capron F; Musset D; Simonneau G; Humbert M
Medicine (Baltimore); 2008 Jul; 87(4):220-233. PubMed ID: 18626305
[TBL] [Abstract][Full Text] [Related]
10. Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease.
Montani D; Lau EM; Descatha A; Jaïs X; Savale L; Andujar P; Bensefa-Colas L; Girerd B; Zendah I; Le Pavec J; Seferian A; Perros F; Dorfmüller P; Fadel E; Soubrier F; Sitbon O; Simonneau G; Humbert M
Eur Respir J; 2015 Dec; 46(6):1721-31. PubMed ID: 26541523
[TBL] [Abstract][Full Text] [Related]
11. Good response to pulmonary arterial hypertension-targeted therapy in 2 pulmonary veno-occlusive disease patients: A case report.
Zhang L; Wang Y; Zhang R
Medicine (Baltimore); 2021 Oct; 100(41):e27334. PubMed ID: 34731104
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary veno-occlusive disease: pathogenesis, risk factors, clinical features and diagnostic algorithm - state of the art.
Szturmowicz M; Kacprzak A; Szołkowska M; Burakowska B; Szczepulska E; Kuś J
Adv Respir Med; 2018; 86(3):. PubMed ID: 29960280
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and survival of Chinese patients diagnosed with pulmonary arterial hypertension who carry BMPR2 or EIF2KAK4 variants.
Zeng Q; Yang H; Liu B; Ma Y; Liu Z; Chen Q; Li W; Luo Q; Zhao Z; Zhou Z; Xiong C
BMC Pulm Med; 2020 May; 20(1):150. PubMed ID: 32471403
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary Capillary Hemangiomatosis and Pulmonary Veno-occlusive Disease.
Chaisson NF; Dodson MW; Elliott CG
Clin Chest Med; 2016 Sep; 37(3):523-34. PubMed ID: 27514598
[TBL] [Abstract][Full Text] [Related]
15. Genetic counselling in a national referral centre for pulmonary hypertension.
Girerd B; Montani D; Jaïs X; Eyries M; Yaici A; Sztrymf B; Savale L; Parent F; Coulet F; Godinas L; Lau EM; Tamura Y; Sitbon O; Soubrier F; Simonneau G; Humbert M
Eur Respir J; 2016 Feb; 47(2):541-52. PubMed ID: 26699722
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and management of pulmonary veno-occlusive disease.
Solinas S; Boucly A; Beurnier A; Kularatne M; Grynblat J; Eyries M; Dorfmüller P; Sitbon O; Humbert M; Montani D
Expert Rev Respir Med; 2023; 17(8):635-649. PubMed ID: 37578057
[TBL] [Abstract][Full Text] [Related]
17. EIF2AK4 mutation in pulmonary veno-occlusive disease: A case report and review of the literature.
Liang L; Ma G; Chen K; Liu Y; Wu X; Ying K; Zhang R
Medicine (Baltimore); 2016 Sep; 95(39):e5030. PubMed ID: 27684876
[TBL] [Abstract][Full Text] [Related]
18. Variable Expressivity of a Founder Mutation in the EIF2AK4 Gene in Hereditary Pulmonary Veno-occlusive Disease and Its Impact on Survival.
Navas Tejedor P; Palomino Doza J; Tenorio Castaño JA; Enguita Valls AB; Rodríguez Reguero JJ; Martínez Meñaca A; Hernández González I; Bueno Zamora H; Lapunzina Badía PD; Escribano Subías P
Rev Esp Cardiol (Engl Ed); 2018 Feb; 71(2):86-94. PubMed ID: 28697925
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary veno-occlusive disease: illustrative cases and literature review.
Lechartier B; Boucly A; Solinas S; Gopalan D; Dorfmüller P; Radonic T; Sitbon O; Montani D
Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38232988
[TBL] [Abstract][Full Text] [Related]
20. Genetics of pulmonary hypertension in the clinic.
Girerd B; Lau E; Montani D; Humbert M
Curr Opin Pulm Med; 2017 Sep; 23(5):386-391. PubMed ID: 28661905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
